FXAIX
Price
$198.55
Change
-$0.55 (-0.28%)
Updated
Nov 4 closing price
NYVBX
Price
$21.34
Change
-$0.18 (-0.84%)
Updated
Nov 4 closing price
Ad is loading...

FXAIX vs NYVBX

Header iconFXAIX vs NYVBX Comparison
Open Charts FXAIX vs NYVBXBanner chart's image
Fidelity 500 Index
Price$198.55
Change-$0.55 (-0.28%)
VolumeN/A
CapitalizationN/A
Davis NY Venture B
Price$21.34
Change-$0.18 (-0.84%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FXAIX vs NYVBX Comparison Chart
Loading...
VS
FXAIX vs. NYVBX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and NYVBX is a Buy.

FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 593B vs. NYVBX (6.66B). FXAIX pays higher dividends than NYVBX: FXAIX (1.31) vs NYVBX (0.13). FXAIX was incepted earlier than NYVBX: FXAIX (14 years) vs NYVBX (30 years). NYVBX is a more actively managed with annual turnover of: 7.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than NYVBX: FXAIX (0) vs NYVBX (1000). FXAIX annual gain was more profitable for investors over the last year : 32.96 vs. NYVBX (10.45). FXAIX return over 5 years is better than : 99.78 vs. NYVBX (-12.93).
FXAIXNYVBXFXAIX / NYVBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years30 years-
Gain YTD21.1316.017351%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets593B6.66B8,901%
Annual Yield % from dividends1.310.131,003%
Returns for 1 year32.9610.45315%
Returns for 3 years27.36-21.11-130%
Returns for 5 years99.78-12.93-772%
Returns for 10 years205.42-42.30-486%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FIZZ47.701.93
+4.22%
National Beverage Corp
PRAX69.991.66
+2.43%
Praxis Precision Medicines
CSGP73.831.33
+1.83%
CoStar Group
SGC15.140.12
+0.80%
Superior Group of Companies
AEON0.88N/A
-0.10%
AEON Biopharma